Table 1.
Demographic characteristics of experimental and control subjects
| Control | Stdev | Ultra high risk | Stdev | p-value | Control | Stdev | Schizophrenia | Stdev | p | |
|---|---|---|---|---|---|---|---|---|---|---|
| N = 14 | N = 14 | - | N=14 | N = 14 | - | |||||
| Age in years | 28.14 | 7.99 | 24.29 | 5.40 | 0.133 a | 46.21 | 13.62 | 47.00 | 9.31 | 0.982 a |
| Years of education | 14.8 | 3.0 | 14.3 | 1.6 | 0.344 a | 12.3 | 3.0 | 12.2 | 2.0 | 0.374a |
| Gender (M:F) | 10:4 | 7:7 | 0.352 b | 12:3 | 12:3 | 1.000 b | ||||
| TSPO genotype (HAB) | 10 | 7 | 0.352 b | 14 | 13 | 0.541 b | ||||
| CAARMS/PANSS | ||||||||||
| Positive | - | - | 11.2 | 4.5 | - | - | 17.0 | 6.1 | - | |
| Negative | - | - | 6.1 | 4.3 | - | - | 14.1 | 4.0 | - | |
| General | - | - | 19.1 | 12.3 | - | - | 32.6 | 8.7 | - | |
| Total | - | - | 49.5 | 21.6 | - | - | 63.7 | 18.1 | - |
a
independent samples t-test.
b
Mann-Whitney U test.
Symptom scales measured in high risk subjects on the CAARMS (comprehensive assessment of the ‘at risk mental state’) and in schizophrenia on the PANSS (positive and negative syndrome scale).